Traded Nov 10, 2026 · largest single transaction ~$157KNot reported under a pre-arranged trading plan
Show all 2 transactions
Nov 10, 2026~$157K · 2,340 sh @ $67.18
DetailsOfficial recordNov 10, 2026~$79K · 1,160 sh @ $67.88
DetailsOfficial record
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
ETON · NASDAQ · Pharmaceutical Preparations
Eton Pharmaceuticals (ETON) · oqro.io/stocks/ETON · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$60.85−0.51 (−0.83%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
12 routine filings (option exercises, shares withheld for taxes, grants, gifts) are not listed here. Show them
Traded Nov 10, 2026 · largest single transaction ~$157KNot reported under a pre-arranged trading plan
Nov 10, 2026~$157K · 2,340 sh @ $67.18
DetailsOfficial recordNov 10, 2026~$79K · 1,160 sh @ $67.88
DetailsOfficial recordTraded Nov 10, 2026 · largest single transaction ~$2.28MNot reported under a pre-arranged trading plan
Nov 10, 2026~$2.28M · 34K sh @ $67.11
DetailsCharles J. Casamento (Director) plans to sell ~$5.34M of Eton Pharmaceuticals
Planned, from payErdogan-Trinkaus Ipek (Officer) plans to sell ~$236K of Eton Pharmaceuticals
Planned, from payInsider selling
Traded Oct 6 · filed 1 day laterNot reported under a pre-arranged trading plan
Since the trade +11.1% · S&P 500 −11.5% · to Nov 20
Eton Pharmaceuticals's Chief Business Officer sold $229K of Eton Pharmaceuticals shares. The filing does not indicate a pre-arranged trading plan.
Krempa David (Officer) plans to sell ~$229K of Eton Pharmaceuticals
Planned, from payTraded Aug 19 – Aug 20, 2025 · largest single transaction ~$632KNot reported under a pre-arranged trading plan
Aug 19, 2025~$632K · 39K sh @ $16.16
DetailsTraded Jun 12 – Jun 16, 2025 · largest single transaction ~$253KNot reported under a pre-arranged trading plan
Jun 12, 2025~$253K · 17K sh @ $14.92
DetailsTraded Jun 10, 2025 · largest single transaction ~$79K
Jun 10, 2025~$79K · 5,000 sh @ $15.82
DetailsOfficial recordTraded Jun 3 – Jun 5, 2025 · largest single transaction ~$1.19MNot reported under a pre-arranged trading plan
Jun 5, 2025~$1.18M · 70K sh @ $16.81
DetailsInsider buying
Traded Oct 23, 2024 · filed 2 days later
Since the trade +648.5% · S&P 500 +19.4% · to Nov 20
A major shareholder of Eton Pharmaceuticals paid $80K out of pocket for Eton Pharmaceuticals shares.
Traded Oct 4 – Oct 8, 2024 · largest single transaction ~$211K
Oct 4, 2024~$102K · 15K sh @ $6.77
DetailsOfficial recordNov 10, 2026~$1.5M · 23K sh @ $66.26
DetailsOfficial recordNov 10, 2026~$961K · 15K sh @ $65.32
DetailsOfficial recordNov 10, 2026~$410K · 6,380 sh @ $64.33
DetailsOfficial recordNov 10, 2026~$197K · 2,903 sh @ $67.87
DetailsOfficial recordAug 20, 2025~$42K · 2,631 sh @ $16.02
DetailsOfficial recordJun 16, 2025~$151K · 10K sh @ $14.73
DetailsOfficial recordJun 13, 2025~$100K · 6,800 sh @ $14.77
DetailsOfficial recordJun 10, 2025~$46K · 2,930 sh @ $15.82
DetailsOfficial recordJun 4, 2025~$1.19M · 70K sh @ $17.00
DetailsOfficial recordJun 3, 2025~$1.06M · 61K sh @ $17.38
DetailsOfficial recordJun 3, 2025~$159K · 8,655 sh @ $18.38
DetailsOfficial recordJun 3, 2025~$7.6K · 400 sh @ $19.02
DetailsOfficial recordOct 8, 2024~$211K · 30K sh @ $7.03
DetailsOfficial recordOct 7, 2024~$72K · 10K sh @ $7.22
DetailsOfficial recordOct 8, 2024~$28K · 3,970 sh @ $7.03
DetailsOfficial recordOct 4, 2024~$13K · 1,852 sh @ $6.77
DetailsOfficial recordOct 7, 2024~$9K · 1,248 sh @ $7.22
DetailsOfficial record0 open-market purchases and 8 open-market sales by insiders of ETON between Feb 17, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Nov 5, 2026. The data provider lists the next release for Mar 17, 2027; that date may change.
PurchaseSale30 days before a release30 days after
| Earnings release | 30 days before | On the day | 30 days after |
|---|---|---|---|
| Nov 5, 2026 | 1 sale | None | 7 sales |
| Aug 13, 2026 | None | None | None |
| May 14, 2026 | None | None | None |
| Mar 19, 2026 | None | None | None |
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies